MP35-14 A 17-GENE ASSAY DRIVES HIGH ACTIVE SURVEILLANCE PERSISTENCE IN CLINICALLY LOW-RISK PROSTATE CANCER: 1 YEAR RESULTS FROM A 1,200 PATIENT PROSPECTIVE OBSERVATIONAL TRIAL